The Day After

A new beginning

Sunday | March 13th 2022

The Day After

Sponsored by

The SARS-CoV-2 pandemic turned the world upside-down and everyone got involved in this huge avalanche of changes which will, no doubt, be regarded by History as a turning point for Humankind. For the last two years, fear, distance, and uncertainty were words filled with great emotion and most of what was taken for granted, suddenly, was called into question. The module The Day After will create a space for discussion, enlightening about what is going to change in the post-pandemic era and everything that we have learned from this historic time, something that will certainly help us create a new version of normal.

Sarah-Jayne Blakemore, PhD

Professor of Psychology and Cognitive Neuroscience at the University of Cambridge
Leader of the Developmental Cognitive Neuroscience Group
Fellowship of the British Academy
Fellowship of the Royal Society of Biology

Sarah-Jayne Blakemore, PhD, is a neuroscientist and Professor of Psychology and Cognitive Neuroscience at the University of Cambridge and a Fellow of the Royal Society of Biology, the British Academy and the Association of Psychological Science. She is the leader of the Developmental Cognitive Neuroscience Group, a research group whose focus is the development of social cognition and decision-making in the human adolescent brain. Prof. Sarah-Jayne Blakemore is Chair of the Royal Society of Biology Education and Science Policy Committee and editor at Proceedings of the National Academy of Sciences and on the advisory board of the Lancet Child & Adolescent Health. She has won multiple awards for her research and books, including the British Psychological Society Doctoral Award 2001, the Swedish Neuropsychology Society Award 2011, the Royal Society Rosalind Franklin Award 2013, the Royal Society Prize for Science Books 2018 and the International Union of Psychological Science Quadrennial Major Advancement in Psychological Science Prize 2020.

language
The Blakemore Lab
Ben Ramalingam

Ben Ramalingam, BSc

Executive Director, United Kingdom Humanitarian Innovation Hub
Lead Consultant to the OECD Development Assistance Committee on Innovation Investments for Development and Humanitarian Issues
Senior Research Associate at the Overseas Development Institute (ODI) Politics and Governance Programme

Ramalingam is currently Executive Director of UK Humanitarian Innovation Hub, a government backed investment programme seeking to find innovative solutions to the worlds biggest challenges in crises and conflict settings. He has worked with and advised many national governments, the Red Cross, the United Nations and numerous NGOs on leadership strategy, innovation and organisational reform issues. He is the author of the 2013 bestselling book Aid on the Edge of Chaos, which was endorsed by four Nobel laureates, and lead author of the IPCC Special Report on Extreme Weather Events in 2012. In 2020, he was appointed Humanitarian Change Maker of the Decade, for being one of the ten people or organisations globally who had done most to improve international crisis responses in the previous decade.

LinkedIn
Jonathan Van-Tam

Sir Jonathan Van-Tam, MD DM

Deputy Chief Medical Officer for England
Most Excellent Order of the British Empire
Fellowship of the Royal College of Pathologists
Fellowship of the Royal Society of Biology
Fellowship of the Academy of Medical Sciences
Fellowship of the Royal Society for Public Health

Professor Jonathan Van-Tam is a British epidemiologist and Public Health professional specialising in influenza, vaccinology, antiviral drugs and pandemic preparedness, having published over 100 scientific papers and written four textbooks. Over the years, Professor Van-Tam has held several leading positions in disease prevention and control, such as – Head of Pandemic Influenza Office, chair of the Expert Advisory group on H5N1 human vaccines, and chair of he UK government’s New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). In 2017 he became Deputy Chief Medical Officer and has gained great visibility during the COVID-19 pandemic, being part of the expert advisory group for the UK’s Vaccine Taskforce.

LinkedIn
Moderator

Válter Fonseca, MD PhD

Professor at the University of Lisbon
Postgraduate researcher at the Institute of Molecular Medicine
Chair Technical Advisory Committee for COVID-19 Vaccination in Portugal
Director of the Department of Quality in Health, Directorate-General for Health

Professor Válter Fonseca completed his medical degree in Medicine at the Faculty of Medicine of the University of Lisbon. He specialized in Internal Medicine and has a PhD in Immunology. His scientific curriculum includes several publications in scientific journals and collaborations as Scientific Reviewer and Clinical Consultant.
Professor Válter Fonseca is an assistant professor of Medicine and Pathophysiology at Faculty of Medicine of the University of Lisbon and a Researcher at the Institute of Molecular Medicine. He is also the Director of the Department of Quality in Health of the Directorate-General for Health and Chair Technical Advisory Committee for COVID-19 Vaccination.

Scientific Committee
Luís Graça, MD PhD
Full Professor of Immunology at the Faculty of Medicine of the University of Lisbon
Group Leader and Principal Investigator at the Lymphocyte Regulation Lab of the Molecular Medicine Institute (IMM)
Co-founder of Acellera Therapeutics
Maria do Céu Machado, MD PhD
Professor of Pediatrics at the Faculty of Medicine of the University of Lisbon
Member of the Nacional Ethics Council for Life Sciences
Vice President of the Portuguese Academy of Medicine and the European Federation of the Academies of Medicine
Miguel Prudêncio, PhD
Biochemist
Group Leader at the Plasmodium Infection & Anti-malarial Interventions Lab of the Molecular Medicine Institute (IMM)
Winner of the Pfizer Clinical Research Prize 2020
Menu